Yusuke Yatabe
Kumamoto University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Yusuke Yatabe.
Psychogeriatrics | 2011
Yusuke Yatabe; Mamoru Hashimoto; Keiichirou Kaneda; Kazuki Honda; Yusuke Ogawa; Seiji Yuuki; Shiho Matsuzaki; Atsuko Tuyuguchi; Hiroko Kashiwagi; Manabu Ikeda
Background: Progressive supranuclear palsy (PSP) is a neurodegenerative disease characterized by supranuclear gaze palsy, postural instability, akinesia and other parkinsonism. Recently, the relationship between PSP and frontotemporal dementia (FTD) has been recognized, which includes clinical, pathological, biochemical and genetic features. However, there have been few studies that directly compared neuropsychiatric symptoms between PSP and FTD. The aim of the present study was to investigate comprehensive psychiatric and behavioural symptoms in PSP and compared them with those in FTD.
Psychogeriatrics | 2009
Mamoru Hashimoto; Yusuke Yatabe; Keiichiro Kaneda; Kazuki Honda; Manabu Ikeda
Background: To evaluate the impact of donepezil hydrochloride on the care burden on family members of patients with Alzheimers disease (AD). At present, donepezil is the only drug approved for the treatment of AD in Japan. Although the care burden on primary caregivers of AD patients comprises both physical and psychological burdens and donepezil is recognized to improve cognitive dysfunction and associated symptoms, there are few data on the effects of the drug on the care burden.
International Psychogeriatrics | 2013
Noriko Hasegawa; Mamoru Hashimoto; Seiji Yuuki; Kazuki Honda; Yusuke Yatabe; K. Araki; Manabu Ikeda
BACKGROUND Delirium and dementia are highly interrelated. However, few comprehensive epidemiological studies have examined this altered state of consciousness superimposed on dementia. We investigated the frequency of delirium in patients with dementia, its prevalence in patients with each dementia type, and its association with cerebrovascular disease (CVD) in patients with neurodegenerative dementias. METHODS We studied 261 consecutive outpatients in the memory clinic of a psychiatric hospital between April 2010 and September 2011. All patients underwent routine laboratory tests and computed tomography (CT), and their Mini-Mental State Examination, Neuropsychiatric Inventory (NPI), Physical Self-Maintenance Scale (PSMS), and Delirium Rating Scale - Revised 98 scores were recorded. The diagnosis of delirium was based on the Diagnostic and Statistical Manual of Mental Disorders, fourth edition, text revision. CVD was detected by CT. RESULTS Among the 206 patients with dementia, delirium was present in 40 (19.4%). The proportion of patients who experienced episodes of delirium was 14.7% in the Alzheimers disease, 34.4% in the vascular dementia, 31.8% in the dementia with Lewy bodies, and none in frontotemporal lobar degeneration. Delirium was frequently observed in patients with dementia and CVD. The NPI total and agitation subscale scores were significantly higher in dementia patients with delirium than in those without delirium. PSMS scores were significantly lower for patients with delirium than for patients without delirium. CONCLUSIONS The frequency of delirium varies with each dementia type. In addition, delirium decreases activities of daily living, exaggerates behavioral and psychological symptoms dementia, and is associated with CVD in patients with neurodegenerative dementias.
Dementia and geriatric cognitive disorders extra | 2015
Mamoru Hashimoto; Yusuke Yatabe; Tomohisa Ishikawa; Ryuji Fukuhara; Keiichiro Kaneda; Kazuki Honda; Seiji Yuki; Yusuke Ogawa; Toru Imamura; Hiroaki Kazui; Naoto Kamimura; Syunichiro Shinagawa; Katsuyoshi Mizukami; Etsuro Mori; Manabu Ikeda
Background/Aims: Behavioral and psychological symptoms of dementia (BPSD) are common in the clinical manifestation of dementia. Although most patients with dementia exhibit some BPSD during the course of the illness, the association of BPSD with the stage of dementia remains unclear. It was the aim of this study to evaluate the impact of severity of dementia on the expression of BPSD in patients with dementia with Lewy bodies (DLB) and Alzheimers disease (AD). Methods: Ninety-seven patients with DLB and 393 patients with AD were recruited from 8 dementia clinics across Japan. BPSD were assessed by the Neuropsychiatric Inventory (NPI). A relationship between BPSD and dementia stage classified by the Clinical Dementia Rating (CDR) in each type of dementia was assessed. Results: No significant difference was seen in NPI total score across CDR staging in the DLB group. On the other hand, the NPI total score significantly increased with dementia stage in the AD group. Conclusion: The relationship of dementia stage with the expression of BPSD was different according to the type of dementia. BPSD and dementia stage were correlated in AD subjects, in whom psychiatric symptoms increase as the disease progresses, but not in DLB subjects.
Psychogeriatrics | 2015
Hibiki Tanaka; Mamoru Hashimoto; Ryuji Fukuhara; Tomohisa Ishikawa; Yusuke Yatabe; Keiichiro Kaneda; Seiji Yuuki; Kazuki Honda; Shiho Matsuzaki; Atsuko Tsuyuguchi; Yutaka Hatada; Manabu Ikeda
The features of behavioural and psychological symptoms of dementia (BPSD) are influenced by dementia stage. In early‐onset Alzheimers disease (EOAD), the association between BPSD and dementia stage remains unclear because of the difficulty of recruiting subjects with a wide range of disease severity. We used a combination of community‐based and hospital‐based approaches to investigate the relationship between dementia severity and BPSD in EOAD patients.
International Journal of Geriatric Psychiatry | 2013
Yusuke Ogawa; Mamoru Hashimoto; Yusuke Yatabe; Keiichiro Kaneda; Kazuki Honda; Seiji Yuuki; Toshinori Hirai; Manabu Ikeda
Cerebral small vessel disease (SVD) is frequently observed in patients with Alzheimers disease (AD). However, the association between SVD and clinical symptoms exhibited by patients with AD remains unclear. This study examined the association of SVD as observed on magnetic resonance imaging (MRI) with behavioural and psychological symptoms of dementia and cognitive function of patients with probable AD.
Psychogeriatrics | 2013
Yusuke Yatabe; Mamoru Hashimoto; Keiichiro Kaneda; Kazuki Honda; Yusuke Ogawa; Seiji Yuuki; Manabu Ikeda
With the recent approval of several new drugs, pharmacological management of Alzheimers disease has become more complicated in Japan. The efficacy and safety of increasing the dose of donepezil to 10 mg daily were assessed in an open‐label study of patients with mild to moderate Alzheimers disease who were showing a diminished response to 5 mg daily.
International Psychogeriatrics | 2013
Kazuki Honda; Mamoru Hashimoto; Yusuke Yatabe; Keiichiro Kaneda; Seiji Yuki; Yusuke Ogawa; Shiho Matsuzaki; Atsuko Tsuyuguchi; Hibiki Tanaka; Hiroko Kashiwagi; Noriko Hasegawa; Tomohisa Ishikawa; Manabu Ikeda
BACKGROUND Dementia with Lewy bodies (DLB) is the second most common type of neurodegenerative dementia. It is frequently difficult to differentiate DLB from Alzheimers disease (AD) and other types of dementia. This study examined the usefulness of monitoring sleep talking for the diagnosis of DLB. METHODS A total of 317 patients with dementia were selected from a consecutive series at the Dementia Clinic of Kumamoto University Hospital. Diagnostic categories consisted of probable DLB (n = 55), probable AD (n = 191), frontotemporal lobar degeneration (FTLD) (n = 16), vascular dementia (VaD) (n = 18), and other/unspecified dementia (n = 37). We evaluated sleep talking in all dementia patients and normal elderly subjects (n = 32) using an originally designed sleep talking questionnaire. RESULTS Sleep talking occurred most frequently in the DLB group (61.8%), followed by the VaD group (33.3%), other/unspecified dementia group (27.0%), AD group (18.8%), FTLD group (12.5%), and normal elderly subjects group (6.3%). The prevalence of sleep talking in the DLB group was significantly higher than in other groups, except in the VaD group. The sleep talking yielded high specificity (81.2%) and some sensitivity (61.8%) for the differential diagnosis of DLB from AD. Furthermore, loud sleep talking may improve the specificity (96.9%). For the differentiation of DLB from all other dementia types, the specificity of sleep talking and loud sleep talking was also high (79.4% and 95.8% respectively). CONCLUSIONS Assessing sleep talking, especially the volume of sleep talking, may be useful in the clinical discrimination of DLB from not only AD but also from all other types of dementia.
PLOS ONE | 2018
Masateru Matsushita; Yusuke Yatabe; Asuka Koyama; Akiko Katsuya; Daisuke Ijichi; Yusuke Miyagawa; Hiroto Ikezaki; Noboru Furukawa; Manabu Ikeda; Mamoru Hashimoto
Introduction To keep up appearances, people with dementia sometimes pretend to know the correct answer, as seen during administration of neuropsychological tests such as the Mini-Mental State Examination (MMSE). These saving appearance responses (SARs) of people with dementia often lead to caregivers and/or medical staff underestimating the severity of dementia and impede proper early initiation of treatment. However, most descriptions of SARs are based on empirical knowledge of clinicians. In this study, we investigated whether SARs are typical communication patterns in people with Alzheimer’s disease (AD), compared with mild cognitive impairment (MCI) or dementia with Lewy bodies (DLB). Methods The participants were 107 outpatients with AD, 16 with mixed AD with cerebrovascular dementia, 55 with MCI, and 30 with DLB. We assessed the occurrence of SARs during the MMSE. The relationships between the SARs and AD were examined by the χ2 test and logistic regression analysis. Results People with AD who showed SARs were 57.9%, whereas those with MCI were 18.2% and DLB were 20.0% (P with Bonferroni correction < 0.05). Although there were significant differences in some variables in each group of diagnosis, logistic regression analysis showed that people with AD were more likely to show SARs than those with MCI (Odds ratio = 3.48, 95% Confidential Interval = 1.18–10.28) and DLB (Odds ratio = 4.24, 95% Confidential Interval = 1.50–12.01), even after controlling for sex, estimated disease duration, MMSE, and frontal assessment battery scores. Conclusion The occurrence of SARs could be found most frequently in people with AD. Clinicians should develop a respectful attitude toward dementia patients with SARs because SARs imply conflicted feelings about questions that patients cannot answer correctly.
Psychogeriatrics | 2017
Masateru Matsushita; Yusuke Yatabe; Asuka Koyama; Yukiko Ueno; Daisuke Ijichi; Hiroto Ikezaki; Mamoru Hashimoto; Noboru Furukawa; Manabu Ikeda
Toritsukuroi is a particular type of behaviour intended to save face or preserve appearances. Clinicians often observe toritsukuroi in people with dementia, but current knowledge about this behaviour is based on clinicians’ empirical knowledge rather than on observational studies. This study was designed to clarify which behaviours are related to toritsukuroi based on neuropsychological examinations.